https://www.marketscreener.com/news/latest/Transgene-First-Patient-Enrolled-in-Expanded-Phase-II-Clinical-Trial-of-TG4001-Avelumab-Vs-Avelum-35693811/?utm_source=telegram&utm_medium=social&utm_campaign=share